Cannara Biotech Inc. (LOVE.V)
CAD 0.68
(0.0%)
CAD 0.68
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 141.52 Million CAD | 12.66% |
| 2022 | 125.61 Million CAD | 36.51% |
| 2021 | 92.02 Million CAD | 67.77% |
| 2020 | 54.85 Million CAD | -19.46% |
| 2019 | 68.1 Million CAD | 135.98% |
| 2018 | 28.86 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 144.82 Million CAD | 2.33% |
| 2024 Q3 | 148.76 Million CAD | 2.02% |
| 2024 Q2 | 145.82 Million CAD | 0.69% |
| 2023 Q1 | 125.42 Million CAD | -0.15% |
| 2023 Q4 | 141.52 Million CAD | 4.54% |
| 2023 FY | 141.52 Million CAD | 12.66% |
| 2023 Q3 | 135.37 Million CAD | 4.82% |
| 2023 Q2 | 129.14 Million CAD | 2.97% |
| 2022 Q2 | 101.69 Million CAD | -0.44% |
| 2022 Q1 | 102.14 Million CAD | 11.0% |
| 2022 FY | 125.61 Million CAD | 36.51% |
| 2022 Q4 | 125.61 Million CAD | 17.59% |
| 2022 Q3 | 106.82 Million CAD | 5.05% |
| 2021 Q4 | 92.02 Million CAD | 58.86% |
| 2021 Q2 | 54.2 Million CAD | 5.12% |
| 2021 FY | 92.02 Million CAD | 67.77% |
| 2021 Q1 | 51.56 Million CAD | -5.99% |
| 2021 Q3 | 57.92 Million CAD | 6.87% |
| 2020 FY | 54.85 Million CAD | -19.46% |
| 2020 Q4 | 54.85 Million CAD | -5.21% |
| 2020 Q3 | 57.86 Million CAD | -2.28% |
| 2020 Q1 | 61.87 Million CAD | -9.14% |
| 2020 Q2 | 59.21 Million CAD | -4.29% |
| 2019 Q4 | 68.1 Million CAD | 0.46% |
| 2019 FY | 68.1 Million CAD | 135.98% |
| 2019 Q3 | 67.79 Million CAD | -3.08% |
| 2019 Q1 | 34.77 Thousand CAD | 0.0% |
| 2019 Q2 | 69.94 Million CAD | 201077.73% |
| 2018 FY | 28.86 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 1.08 Million CAD | -12928.84% |
| CanadaBis Capital Inc. | 22.96 Million CAD | -516.305% |
| Decibel Cannabis Company Inc. | 142.98 Million CAD | 1.024% |
| Delivra Health Brands Inc. | 10.05 Million CAD | -1307.901% |
| Entourage Health Corp. | 31.39 Million CAD | -350.812% |
| Lifeist Wellness Inc. | 13.39 Million CAD | -956.204% |
| Medicure Inc. | 28.05 Million CAD | -404.374% |
| PharmaCielo Ltd. | 22.28 Million CAD | -534.931% |
| Rubicon Organics Inc. | 54.89 Million CAD | -157.824% |
| BioSyent Inc. | 41.52 Million CAD | -240.78% |
| Voyageur Pharmaceuticals Ltd. | 2.16 Million CAD | -6440.867% |